1. LncRNA-MALAT1 contributes to the cisplatin-resistance of lung cancer by upregulating MRP1 and MDR1 via STAT3 activation
    Zhixian Fang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  2. Characterization of phenolic extracts from Brava extra virgin olive oils and their cytotoxic effects on MCF-7 breast cancer cells
    Patricia Reboredo-Rodríguez et al, 2018, Food and Chemical Toxicology CrossRef
  3. Apigenin: A natural bioactive flavone-type molecule with promising therapeutic function
    Dharambir Kashyap et al, 2018, Journal of Functional Foods CrossRef
  4. Mechanistic evaluation of phytochemicals in breast cancer remedy: current understanding and future perspectives
    Muhammad Younas et al, 2018, RSC Adv. CrossRef
  5. Midkine downregulation increases the efficacy of quercetin on prostate cancer stem cell survival and migration through PI3K/AKT and MAPK/ERK pathway
    Suat Erdogan et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  6. Flavonoids: New Frontier for Immuno-Regulation and Breast Cancer Control
    Meenakshi Sudhakaran et al, 2019, Antioxidants CrossRef
  7. Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids
    Qingmei Ye et al, 2019, Front. Oncol. CrossRef
  8. null
    Ajay Sharma et al, 2019 CrossRef
  9. The Mediterranean Diet and Breast Cancer: A Personalised Approach
    Amani Al Shaikh et al, 2019, Healthcare CrossRef
  10. null
    Madhumita Roy et al, 2019 CrossRef
  11. 2-Amino-4-(1-piperidine) pyridine exhibits inhibitory effect on colon cancer through suppression of FOXA2 expression
    Jieshu Wang et al, 2019, 3 Biotech CrossRef
  12. FOXA2 promotes the proliferation, migration and invasion, and epithelial mesenchymal transition in colon cancer.
    Baolei Wang et al, 0 CrossRef
  13. null
    Sevim Beyza Gürler et al, 2020 CrossRef
  14. Phytochemical Targeting of STAT3 Orchestrated Lipid Metabolism in Therapy-Resistant Cancers
    Carmen Tse et al, 2020, Biomolecules CrossRef
  15. Apigenin inhibits growth and migration of fibroblasts by suppressing FAK signaling
    Hongyi Wang et al, 2019, Aging CrossRef
  16. Apigenin by targeting hnRNPA2 sensitizes triple-negative breast cancer spheroids to doxorubicin-induced apoptosis and regulates expression of ABCC4 and ABCG2 drug efflux transporters
    Meenakshi Sudhakaran et al, 2020, Biochemical Pharmacology CrossRef
  17. CYP1B1 as a therapeutic target in cardio-oncology
    Alexa N. Carrera et al, 2020 CrossRef
  18. Apigenin, a Partial Antagonist of the Estrogen Receptor (ER), Inhibits ER-Positive Breast Cancer Cell Proliferation through Akt/FOXM1 Signaling
    Thu Ha Pham et al, 2021, IJMS CrossRef
  19. Polyphenolic molecules targeting signal transducer and activator of transcription 3 pathway for the treatment of cancer
    Md. Abdul Aziz et al, 2021, Life Sciences CrossRef
  20. Molecular mechanism and pharmacokinetics of flavonoids in the treatment of resistant EGF receptor‐mutated non‐small‐cell lung cancer: A narrative review
    Xuewen Wang et al, 2021, Br J Pharmacol CrossRef
  21. Nanoplatform-based natural products co-delivery system to surmount cancer multidrug-resistant
    Yan Liang et al, 2021, Journal of Controlled Release CrossRef
  22. null
    Didem Şöhretoğlu et al, 2021 CrossRef
  23. Influence of the Bioactive Diet Components on the Gene Expression Regulation
    Justyna Mierziak et al, 2021, Nutrients CrossRef
  24. Chemoprotective and chemosensitizing effects of apigenin on cancer therapy
    Zahra Nozhat et al, 2021, Cancer Cell Int CrossRef
  25. Rationalizing the therapeutic potential of apigenin against cancer
    Semim Akhtar Ahmed et al, 2021, Life Sciences CrossRef
  26. ER and PGR Targeting Ability of Phytocompounds Derived from Centella asiatica and Andrographis paniculata: An In-silico Approach
    Geeta Swargiary et al, 2022, Journal of Herbal Medicine CrossRef
  27. Reckoning apigenin and kaempferol as a potential multi-targeted inhibitor of EGFR/HER2-MEK pathway of metastatic colorectal cancer identified using rigorous computational workflow
    Abhilasha Sharma et al, 2022, Mol Divers CrossRef
  28. null
    Marilyn E. Morris et al, 2022 CrossRef
  29. Chemotherapeutic effects of Apigenin in breast cancer: preclinical evidence and molecular mechanisms; enhanced bioavailability by nanoparticles
    Moein Adel et al, 2022, Biotechnology Reports CrossRef
  30. null
    Saabira Banu Sahubar Sadik et al, 2022 CrossRef
  31. Identification of multi-target anti-cancer agents from TCM formula by in silico prediction and in vitro validation
    Bao-Yue ZHANG et al, 2022, Chinese Journal of Natural Medicines CrossRef
  32. Comparative Study of Antiproliferative Activity in Different Plant Parts of Phaleria macrocarpa and the Underlying Mechanism of Action
    Yuyun Ika Christina et al, 2022, The Scientific World Journal CrossRef
  33. Apigenin in Cancer Prevention and Therapy: A Systematic Review and Meta-Analysis of Animal Models
    Deepti Singh et al, 2022, Critical Reviews in Oncology/Hematology CrossRef
  34. Exploring Molecular Targets and Mechanisms of Apigenin in the Treatment of Papillary Thyroid Carcinoma Based on Network Pharmacology and Molecular Docking Analysis
    Dongyu Li et al, 2022, Natural Product Communications CrossRef
  35. Phytochemicals, Biological Activities, Molecular Mechanisms, and Future Prospects of Plantago asiatica L.
    Shi-Yuan Wen et al, 2022, J. Agric. Food Chem. CrossRef
  36. Anticancer plant-derivatives: deciphering their oncopreventive and therapeutic potential in molecular terms
    Rekha Gahtori et al, 2023, Futur J Pharm Sci CrossRef
  37. Effects of Apigenin on Pharmacokinetics of Dasatinib and Probable Interaction Mechanism
    Mohammad Raish et al, 2023, Molecules CrossRef
  38. p‑STAT3 influences doxorubicin and etoposide resistance of A549 cells grown in an in vitro 3D culture model
    Siriporn Keeratichamroen et al, 2023, Oncol Rep CrossRef
  39. Flavonoids for the Treatment of Breast Cancer, Present Status and Future Prospective
    Sonali Sahoo et al, 2023, ACAMC CrossRef
  40. The mechanisms of multidrug resistance of breast cancer and research progress on related reversal agents
    Shiwen Yu et al, 2023, Bioorganic & Medicinal Chemistry CrossRef
  41. Potential of natural flavonoids to target breast cancer angiogenesis (review)
    Yuetong Wang et al, 2024, British J Pharmacology CrossRef
  42. RNA-Binding Proteins in Breast Cancer: Biological Implications and Therapeutic Opportunities
    Shimeng Wang et al, 2024, Critical Reviews in Oncology/Hematology CrossRef
  43. Apigenin’s Modulation of Doxorubicin Efficacy in Breast Cancer
    Aleksandra Golonko et al, 2024, Molecules CrossRef